1. Home
  2. TARS
  3. TARS News

Latest Tarsus Pharmaceuticals Inc. (TARS) News on October 29, 2025

Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last?
TARS

Zacks

23 days ago

Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last?

TARS

MT Newswires

4 months ago

Tarsus Pharmaceuticals Insider Sold Shares Worth $550,035, According to a Recent SEC Filing

TARS

MT Newswires

5 months ago

Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $72, Maintains Outperform Rating

Tarsus to Participate in Upcoming Investor Conferences
TARS

GlobeNewswire

5 months ago

Tarsus to Participate in Upcoming Investor Conferences

Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
TARS

Zacks

5 months ago

Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Tarsus to Participate in Upcoming Investor Conferences
TARS

GlobeNewswire

6 months ago

Tarsus to Participate in Upcoming Investor Conferences

Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts
TARS

Insider Monkey

6 months ago

Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts

Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts
TARS

Simply Wall St.

6 months ago

Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts

Tarsus Pharmaceuticals Inc (TARS) Q1 2025 Earnings Call Highlights: Record Sales Surge and ...
TARS

GuruFocus.com

6 months ago

Tarsus Pharmaceuticals Inc (TARS) Q1 2025 Earnings Call Highlights: Record Sales Surge and ...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
TARS

Zacks

6 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements
TARS

GlobeNewswire

6 months ago

Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements

Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High?
TARS

Zacks

6 months ago

Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High?

Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline
TARS

Zacks

6 months ago

Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
TARS

GlobeNewswire

6 months ago

Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting
TARS

GlobeNewswire

6 months ago

Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting

TARS

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 03/24/2025

TARS

MT Newswires

7 months ago

Tarsus Pharmaceuticals Insider Sold Shares Worth $1,163,050, According to a Recent SEC Filing

TARS

MT Newswires

8 months ago

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

TARS

MT Newswires

8 months ago

Tarsus Pharmaceuticals Prices Upsized $125 Million Equity Offering

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
TARS

GlobeNewswire

8 months ago

Tarsus Announces Pricing of Upsized $125.0 Million Public Offering

Tarsus Announces Proposed $100.0 Million Public Offering
TARS

GlobeNewswire

8 months ago

Tarsus Announces Proposed $100.0 Million Public Offering

Tarsus to Participate in Upcoming Investor Conference
TARS

GlobeNewswire

8 months ago

Tarsus to Participate in Upcoming Investor Conference

TARS

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Tarsus Pharmaceuticals Inc Earnings Call

Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...
TARS

GuruFocus.com

8 months ago

Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ...

TARS

MT Newswires

8 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Tops Revenue Estimates
TARS

Zacks

8 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Tops Revenue Estimates

TARS

MT Newswires

8 months ago

Tarsus Pharmaceuticals Q4 Loss Narrows, Revenue Rises

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements
TARS

GlobeNewswire

8 months ago

Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements

Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Report Preview: What To Look For
TARS

GuruFocus.com

8 months ago

Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Report Preview: What To Look For

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
TARS

GlobeNewswire

8 months ago

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
TARS

Simply Wall St.

9 months ago

Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

TARS

MT Newswires

9 months ago

BofA Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $74

Tarsus to Participate in Upcoming Investor Conferences
TARS

GlobeNewswire

9 months ago

Tarsus to Participate in Upcoming Investor Conferences

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?
TARS

Zacks

9 months ago

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

TARS

MT Newswires

9 months ago

Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $72 From $65, Keeps Outperform Rating

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
TARS

Insider Monkey

9 months ago

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround
TARS

Zacks

9 months ago

Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
TARS

GlobeNewswire

10 months ago

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?
TARS

Zacks

10 months ago

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run
TARS

Investor's Business Daily

10 months ago

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
TARS

Zacks

10 months ago

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
TARS

Zacks

10 months ago

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet
TARS

Zacks

a year ago

Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet

Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade
TARS

Zacks

a year ago

Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade

Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
TARS

Simply Wall St.

a year ago

Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

TARS

MT Newswires

a year ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $65 From $63, Maintains Outperform Rating

Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
TARS

GuruFocus.com

a year ago

Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates
TARS

Zacks

a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates

TARS

MT Newswires

a year ago

Tarsus Pharmaceuticals Q3 Loss Narrows, Revenue Surges

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
TARS

GlobeNewswire

a year ago

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
TARS

GlobeNewswire

a year ago

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
TARS

Zacks

a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
TARS

GlobeNewswire

a year ago

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
TARS

GlobeNewswire

a year ago

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?
TARS

Zacks

a year ago

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
TARS

Zacks

a year ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%
TARS

GlobeNewswire

a year ago

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ...
TARS

GuruFocus.com

a year ago

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ...

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
TARS

GlobeNewswire

a year ago

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
TARS

GlobeNewswire

a year ago

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues
TARS

Simply Wall St.

a year ago

Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues

TARS

MT Newswires

a year ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $63 From $61, Maintains Outperform Rating

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
TARS

Zacks

a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
TARS

GlobeNewswire

a year ago

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
TARS

GlobeNewswire

a year ago

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?
TARS

Simply Wall St.

a year ago

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
TARS

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

TARS

Business Wire

a year ago

Form 8.3 - Darktrace plc

TARS

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win
TARS

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
TARS

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

TARS

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
TARS

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

TARS

Business Wire

a year ago

Form 8.3 - International Paper Company

Tarsus to Participate in Upcoming Investor Conferences
TARS

GlobeNewswire

a year ago

Tarsus to Participate in Upcoming Investor Conferences

Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates
TARS

Simply Wall St.

a year ago

Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates

Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
TARS

Simply Wall St.

a year ago

Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
TARS

GlobeNewswire

a year ago

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript
TARS

Insider Monkey

a year ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript

TARS

MT Newswires

a year ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating

TARS

GuruFocus.com

a year ago

Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
TARS

Zacks

a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates

Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
TARS

GlobeNewswire

a year ago

Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements

Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?
TARS

Zacks

a year ago

Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
TARS

GlobeNewswire

a year ago

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
TARS

GlobeNewswire

2 years ago

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
TARS

Simply Wall St.

2 years ago

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%

Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
TARS

Zacks

2 years ago

Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know

Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
TARS

Insider Monkey

2 years ago

Aggressive Stock Portfolio: 13 Stocks Picked by Analysts

Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
TARS

Zacks

2 years ago

Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why

How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
TARS

Zacks

2 years ago

How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%

Tarsus to Participate at Upcoming Investor Conferences
TARS

GlobeNewswire

2 years ago

Tarsus to Participate at Upcoming Investor Conferences

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
TARS

GlobeNewswire

2 years ago

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
TARS

Simply Wall St.

2 years ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Tarsus Announces Pricing of $100.0 Million Public Offering
TARS

GlobeNewswire

2 years ago

Tarsus Announces Pricing of $100.0 Million Public Offering

Tarsus Announces Proposed $100.0 Million Public Offering
TARS

GlobeNewswire

2 years ago

Tarsus Announces Proposed $100.0 Million Public Offering

Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts
TARS

Simply Wall St.

2 years ago

Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts

Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy
TARS

Zacks

2 years ago

Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript
TARS

Insider Monkey

2 years ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript

Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
TARS

Simply Wall St.

2 years ago

Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Share on Social Networks: